Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Ranbaxy (UK) Limited, 5th floor, Hyde Park, Hayes 3, 11 Millington Road, Hayes, UB3 4AZ, United Kingdom
Ciprofloxacin 250 mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablet. White, round film-coated tablets debossed with “250” on one side and plain on the other side. |
Each film-coated tablet contains Ciprofloxacin hydrochloride equivalent to Ciprofloxacin 250 mg.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Ciprofloxacin |
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
List of Excipients |
---|
Core tablet: Microcrystalline cellulose Film-coating: Hypromellose |
The tablets are available in blisters comprising of:
Packs of 1, 8, 10, 14, 16, 20, 28, 32 and 100 tablets per carton are available.
Not all pack sizes may be marketed.
Ranbaxy (UK) Limited, 5th floor, Hyde Park, Hayes 3, 11 Millington Road, Hayes, UB3 4AZ, United Kingdom
PL 14894/0022
15 December 2000
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.